Literature DB >> 17616785

Lymphocyte gene expression in subjects fed a low-choline diet differs between those who develop organ dysfunction and those who do not.

Mihai D Niculescu1, Kerry-Ann da Costa, Leslie M Fischer, Steven H Zeisel.   

Abstract

BACKGROUND: Some humans fed a low-choline diet develop hepatosteatosis, liver and muscle damage, and lymphocyte apoptosis. The risk of developing such organ dysfunction is increased by the presence of single-nucleotide polymorphisms (SNPs) in genes involved in folate and choline metabolism.
OBJECTIVE: We investigated whether these changes that occur in the expression of many genes when humans are fed a low-choline diet differ between subjects who develop organ dysfunction and those who do not. We also investigated whether expression changes were dependent on the presence of the SNPs of interest.
DESIGN: Thirty-three subjects aged 20-67 y were fed for 10 d a baseline diet containing the recommended adequate intake of choline. They then were fed a low-choline diet for up to 42 d or until they developed organ dysfunction. Blood was collected at the end of each phase, and peripheral lymphocytes were isolated and used for genotyping and for gene expression profiling with the use of microarray hybridization.
RESULTS: Feeding a low-choline diet changed the expression of 259 genes, and the profiles of subjects who developed and those who did not develop signs of organ dysfunction differed. Group clustering and gene ontology analyses found that the diet-induced changes in gene expression profiles were significantly influenced by the SNPs of interest and that the gene expression phenotype of the variant gene carriers differed significantly even with the baseline diet.
CONCLUSION: These findings support our hypothesis that a person's susceptibility to organ dysfunction when fed a low-choline diet is modulated by specific SNPs in genes involved in folate and choline metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616785      PMCID: PMC2587282          DOI: 10.1093/ajcn/86.1.230

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  26 in total

1.  Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains.

Authors:  Mihai D Niculescu; Corneliu N Craciunescu; Steven H Zeisel
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

2.  Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study.

Authors:  Eunyoung Cho; Steven H Zeisel; Paul Jacques; Jacob Selhub; Lauren Dougherty; Graham A Colditz; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2006-04       Impact factor: 7.045

3.  Gene expression of human T lymphocytes cell cycle: experimental and bioinformatic analysis.

Authors:  Luca Giacomelli; Claudio Nicolini
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

4.  Common genetic polymorphisms affect the human requirement for the nutrient choline.

Authors:  Kerry-Ann da Costa; Olga G Kozyreva; Jiannan Song; Joseph A Galanko; Leslie M Fischer; Steven H Zeisel
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

5.  Introduction of fast MR imaging in the assessment of hepatic steatosis.

Authors:  M H Fishbein; K G Gardner; C J Potter; P Schmalbrock; M A Smith
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

6.  Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.

Authors:  Tomasz Nowak; Danuta Januszkiewicz; Mariola Zawada; Monika Pernak; Krzysztof Lewandowski; Jolanta Rembowska; Karina Nowicka; Przemyslaw Mankowski; Jerzy Nowak
Journal:  Oncol Rep       Date:  2006-08       Impact factor: 3.906

Review 7.  Human telomere biology: pitfalls of moving from the laboratory to epidemiology.

Authors:  Abraham Aviv; Ana M Valdes; Tim D Spector
Journal:  Int J Epidemiol       Date:  2006-09-22       Impact factor: 7.196

8.  Maternal nutrient intakes and risk of orofacial clefts.

Authors:  Gary M Shaw; Suzan L Carmichael; Cecile Laurent; Sonja A Rasmussen
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

9.  Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans.

Authors:  Martin Kohlmeier; Kerry-Ann da Costa; Leslie M Fischer; Steven H Zeisel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

10.  Sex and menopausal status influence human dietary requirements for the nutrient choline.

Authors:  Leslie M Fischer; Kerry Ann daCosta; Lester Kwock; Paul W Stewart; Tsui-Shan Lu; Sally P Stabler; Robert H Allen; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

View more
  5 in total

1.  Choline.

Authors: 
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

2.  De novo fatty acid synthesis at the mitotic exit is required to complete cellular division.

Authors:  Natalia Scaglia; Svitlana Tyekucheva; Giorgia Zadra; Cornelia Photopoulos; Massimo Loda
Journal:  Cell Cycle       Date:  2014-01-13       Impact factor: 4.534

3.  MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-choline.

Authors:  Jian Yan; Wei Wang; Jesse F Gregory; Olga Malysheva; J Thomas Brenna; Sally P Stabler; Robert H Allen; Marie A Caudill
Journal:  Am J Clin Nutr       Date:  2010-12-01       Impact factor: 7.045

4.  Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men.

Authors:  William Shin; Jian Yan; Christian M Abratte; Francoise Vermeylen; Marie A Caudill
Journal:  J Nutr       Date:  2010-03-10       Impact factor: 4.798

Review 5.  Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease.

Authors:  Cristina Bauset; Laura Gisbert-Ferrándiz; Jesús Cosín-Roger
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.